Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

Plasma membrane cholesterol regulates the allosteric binding of 1-methyl-4-phenylpyridinium (MPP+) to organic cation transporter 2 (OCT2, SLC22A2).

Hoermann S, Gai Z, Kullak-Ublick GA, Visentin M.

J Pharmacol Exp Ther. 2019 Oct 17. pii: jpet.119.260877. doi: 10.1124/jpet.119.260877. [Epub ahead of print]

2.

Renal glycosuria as a novel early sign of colistin-induced kidney damage in mice.

Samodelov SL, Visentin M, Gai Z, Häusler S, Kullak-Ublick GA.

Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01650-19. doi: 10.1128/AAC.01650-19. [Epub ahead of print]

3.

Renal Reabsorption of Folates: Pharmacological and Toxicological Snapshots.

Samodelov SL, Gai Z, Kullak-Ublick GA, Visentin M.

Nutrients. 2019 Oct 2;11(10). pii: E2353. doi: 10.3390/nu11102353. Review.

4.

microRNA-206 modulates the hepatic expression of the organic anion-transporting polypeptide 1B1.

El Saadany T, van Rosmalen B, Gai Z, Hiller C, Verheij J, Stieger B, van Gulik T, Visentin M, Kullak-Ublick GA.

Liver Int. 2019 Aug 13. doi: 10.1111/liv.14212. [Epub ahead of print]

PMID:
31408569
5.

Lipid Accumulation and Chronic Kidney Disease.

Gai Z, Wang T, Visentin M, Kullak-Ublick GA, Fu X, Wang Z.

Nutrients. 2019 Mar 28;11(4). pii: E722. doi: 10.3390/nu11040722. Review.

6.

Molecular Mechanisms of Colistin-Induced Nephrotoxicity.

Gai Z, Samodelov SL, Kullak-Ublick GA, Visentin M.

Molecules. 2019 Feb 12;24(3). pii: E653. doi: 10.3390/molecules24030653. Review.

7.

Serotonin uptake is required for Rac1 activation in Kras-induced acinar-to-ductal metaplasia in the pancreas.

Saponara E, Visentin M, Baschieri F, Seleznik G, Martinelli P, Esposito I, Buschmann J, Chen R, Parrotta R, Borgeaud N, Bombardo M, Malagola E, Caflisch A, Farhan H, Graf R, Sonda S.

J Pathol. 2018 Nov;246(3):352-365. doi: 10.1002/path.5147. Epub 2018 Oct 4.

PMID:
30058725
8.

Fluorocholine Transport Mediated by the Organic Cation Transporter 2 (OCT2, SLC22A2): Implication for Imaging of Kidney Tumors.

Visentin M, Torozi A, Gai Z, Häusler S, Li C, Hiller C, Schraml PH, Moch H, Kullak-Ublick GA.

Drug Metab Dispos. 2018 Aug;46(8):1129-1136. doi: 10.1124/dmd.118.081091. Epub 2018 May 24.

PMID:
29794161
9.

Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation.

Gai Z, Visentin M, Gui T, Zhao L, Thasler WE, Häusler S, Hartling I, Cremonesi A, Hiller C, Kullak-Ublick GA.

Mol Pharmacol. 2018 Aug;94(2):802-811. doi: 10.1124/mol.117.111047. Epub 2018 May 9.

PMID:
29743187
10.

Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy.

Bedini N, Cicchetti A, Palorini F, Magnani T, Zuco V, Pennati M, Campi E, Allavena P, Pesce S, Villa S, Avuzzi B, Morlino S, Visentin ME, Zaffaroni N, Rancati T, Valdagni R.

Dis Markers. 2018 Feb 25;2018:9128128. doi: 10.1155/2018/9128128. eCollection 2018.

11.

Colistin is substrate of the carnitine/organic cation transporter 2 (OCTN2, SLC22A5).

Visentin M, Gai Z, Torozi A, Hiller C, Kullak-Ublick GA.

Drug Metab Dispos. 2017 Dec;45(12):1240-1244. doi: 10.1124/dmd.117.077248. Epub 2017 Oct 6.

PMID:
28986476
12.

Drug-induced bile duct injury.

Visentin M, Lenggenhager D, Gai Z, Kullak-Ublick GA.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1498-1506. doi: 10.1016/j.bbadis.2017.08.033. Epub 2017 Sep 4. Review.

13.

Results of an interlaboratory comparison of analytical methods for quantification of anhydrosugars and biosugars in atmospheric aerosol.

Chiara Pietrogrande M, Barbaro E, Bove MC, Clauser G, Colombi C, Corbella L, Cuccia E, Dalla Torre S, Decesari S, Fermo P, Gambaro A, Gianelle V, Ielpo P, Larcher R, Lazzeri P, Massabò D, Melchionna G, Nardin T, Paglione M, Perrino C, Prati P, Visentin M, Zanca N, Zangrando R.

Chemosphere. 2017 Oct;184:269-277. doi: 10.1016/j.chemosphere.2017.05.131. Epub 2017 May 26.

14.

Optimization of an ultrasound-assisted derivatization for GC/MS analysis of oxygenated organic species in atmospheric aerosol.

Pietrogrande MC, Manarini F, Quintana JB, Rodil R, Villaverde-de-Sáa E, Visentin M.

Anal Bioanal Chem. 2017 Jul;409(17):4279-4291. doi: 10.1007/s00216-017-0379-6. Epub 2017 May 18.

PMID:
28516280
15.

Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions.

Visentin M, van Rosmalen BV, Hiller C, Bieze M, Hofstetter L, Verheij J, Kullak-Ublick GA, Koepsell H, Phoa SS, Tamai I, Bennink RJ, van Gulik TM, Stieger B.

Drug Metab Dispos. 2017 Feb;45(2):166-173. doi: 10.1124/dmd.116.072371. Epub 2016 Nov 30.

PMID:
27903597
16.

Contribution of occupational factors to the incidence and persistence of chronic low back pain among workers: results from the longitudinal VISAT study.

Esquirol Y, Niezborala M, Visentin M, Leguevel A, Gonzalez I, Marquié JC.

Occup Environ Med. 2017 Mar;74(4):243-251. doi: 10.1136/oemed-2015-103443. Epub 2016 Sep 26.

PMID:
27672181
17.

Urban PM2.5 oxidative potential: Importance of chemical species and comparison of two spectrophotometric cell-free assays.

Visentin M, Pagnoni A, Sarti E, Pietrogrande MC.

Environ Pollut. 2016 Dec;219:72-79. doi: 10.1016/j.envpol.2016.09.047. Epub 2016 Sep 20.

PMID:
27661730
18.

Direct observation of aqueous secondary organic aerosol from biomass-burning emissions.

Gilardoni S, Massoli P, Paglione M, Giulianelli L, Carbone C, Rinaldi M, Decesari S, Sandrini S, Costabile F, Gobbi GP, Pietrogrande MC, Visentin M, Scotto F, Fuzzi S, Facchini MC.

Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10013-8. doi: 10.1073/pnas.1602212113. Epub 2016 Aug 22.

19.

Organic Cation Transporter 2 Overexpression May Confer an Increased Risk of Gentamicin-Induced Nephrotoxicity.

Gai Z, Visentin M, Hiller C, Krajnc E, Li T, Zhen J, Kullak-Ublick GA.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5573-80. doi: 10.1128/AAC.00907-16. Print 2016 Sep.

20.

32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.

Langsteger W, Rezaee A, Loidl W, Geinitz HS, Fitz F, Steinmair M, Broinger G, Pallwien-Prettner L, Beheshti M, Imamovic L, Beheshti M, Rendl G, Hackl D, Tsybrovsky O, Steinmair M, Emmanuel K, Moinfar F, Pirich C, Langsteger W, Bytyqi A, Karanikas G, Mayerhöfer M, Koperek O, Niederle B, Hartenbach M, Beyer T, Herrmann K, Czernin J, Rausch I, Rust P, DiFranco MD, Lassen M, Stadlbauer A, Mayerhöfer ME, Hartenbach M, Hacker M, Beyer T, Binzel K, Magnussen R, Wei W, Knopp MU, Flanigan DC, Kaeding C, Knopp MV, Leisser A, Nejabat M, Hartenbach M, Kramer G, Krainer M, Hacker M, Haug A, Lehnert W, Schmidt K, Kimiaei S, Bronzel M, Kluge A, Wright CL, Binzel K, Zhang J, Wuthrick E, Maniawski P, Knopp MV, Blaickner M, Rados E, Huber A, Dulovits M, Kulkarni H, Wiessalla S, Schuchardt C, Baum RP, Knäusl B, Georg D, Bauer M, Wulkersdorfer B, Wadsak W, Philippe C, Haslacher H, Zeitlinger M, Langer O, Bauer M, Feldmann M, Karch R, Wadsak W, Zeitlinger M, Koepp MJ, Asselin MC, Pataraia E, Langer O, Zeilinger M, Philippe C, Dumanic M, Pichler F, Pilz J, Hacker M, Wadsak W, Mitterhauser M, Nics L, Steiner B, Hacker M, Mitterhauser M, Wadsak W, Traxl A, Wanek T, Kryeziu K, Mairinger S, Stanek J, Berger W, Kuntner C, Langer O, Mairinger S, Wanek T, Traxl A, Krohn M, Stanek J, Filip T, Sauberer M, Kuntner C, Pahnke J, Langer O, Svatunek D, Denk C, Wilkovitsch M, Wanek T, Filip T, Kuntner-Hannes C, Fröhlich J, Mikula H, Denk C, Svatunek D, Wanek T, Mairinger S, Stanek J, Filip T, Fröhlich J, Mikula H, Kuntner-Hannes C, Balber T, Singer J, Fazekas J, Rami-Mark C, Berroterán-Infante N, Jensen-Jarolim E, Wadsak W, Hacker M, Viernstein H, Mitterhauser M, Denk C, Svatunek D, Sohr B, Mikula H, Fröhlich J, Wanek T, Kuntner-Hannes C, Filip T, Pfaff S, Philippe C, Mitterhauser M, Hartenbach M, Hacker M, Wadsak W, Wanek T, Halilbasic E, Visentin M, Mairinger S, Stieger B, Kuntner C, Trauner M, Langer O, Lam P, Aistleitner M, Eichinger R, Artner C, Eidherr H, Vraka C, Haug A, Mitterhauser M, Nics L, Hartenbach M, Hacker M, Wadsak W, Kvaternik H, Müller R, Hausberger D, Zink C, Aigner RM, Cossío U, Asensio M, Montes A, Akhtar S, Te Welscher Y, van Nostrum R, Gómez-Vallejo V, Llop J, VandeVyver F, Barclay T, Lippens N, Troch M, Hehenwarter L, Egger B, Holzmannhofer J, Rodrigues-Radischat M, Pirich C, Pötsch N, Rausch I, Wilhelm D, Weber M, Furtner J, Karanikas G, Wöhrer A, Mitterhauser M, Hacker M, Traub-Weidinger T, Cassou-Mounat T, Balogova S, Nataf V, Calzada M, Huchet V, Kerrou K, Devaux JY, Mohty M, Garderet L, Talbot JN, Stanzel S, Pregartner G, Schwarz T, Bjelic-Radisic V, Liegl-Atzwanger B, Aigner R, Stanzel S, Quehenberger F, Aigner RM, Marković AK, Janković M, Jerković VM, Paskaš M, Pupić G, Džodić R, Popović D, Fornito MC, Familiari D, Koranda P, Polzerová H, Metelková I, Henzlová L, Formánek R, Buriánková E, Kamínek M, Thomson WH, Lewis C, Thomson WH, O'Brien J, James G, Notghi A, Huber H, Stelzmüller I, Wunn R, Mandl M, Fellner F, Lamprecht B, Gabriel M, Fornito MC, Leonardi G, Thomson WH, O'Brien J, James G, Hudzietzová J, Sabol J, Fülöp M.

EJNMMI Res. 2016 Apr;6(Suppl 1):32. doi: 10.1186/s13550-016-0168-9. Epub 2016 Apr 18.

21.

Final design of the beam source for the MITICA injector.

Marcuzzi D, Agostinetti P, Dalla Palma M, De Muri M, Chitarin G, Gambetta G, Marconato N, Pasqualotto R, Pavei M, Pilan N, Rizzolo A, Serianni G, Toigo V, Trevisan L, Visentin M, Zaccaria P, Zaupa M, Boilson D, Graceffa J, Hemsworth RS, Choi CH, Marti M, Roux K, Singh MJ, Masiello A, Froeschle M, Heinemann B, Nocentini R, Riedl R, Tobari H, de Esch HP, Muvvala VN.

Rev Sci Instrum. 2016 Feb;87(2):02B309. doi: 10.1063/1.4932615.

PMID:
26932037
22.

Characteristics and major sources of carbonaceous aerosols in PM2.5 in Emilia Romagna Region (Northern Italy) from four-year observations.

Pietrogrande MC, Bacco D, Ferrari S, Ricciardelli I, Scotto F, Trentini A, Visentin M.

Sci Total Environ. 2016 May 15;553:172-183. doi: 10.1016/j.scitotenv.2016.02.074. Epub 2016 Feb 27.

PMID:
26925729
23.

Influence of 24-Nor-Ursodeoxycholic Acid on Hepatic Disposition of [(18)F]Ciprofloxacin, a Positron Emission Tomography Study in Mice.

Wanek T, Halilbasic E, Visentin M, Mairinger S, Römermann K, Stieger B, Kuntner C, Müller M, Langer O, Trauner M.

J Pharm Sci. 2016 Jan;105(1):106-12. doi: 10.1016/j.xphs.2015.11.014. Epub 2016 Jan 13.

PMID:
26852845
24.

Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2.

Visentin M, Stieger B, Merz M, Kullak-Ublick GA.

J Pharmacol Exp Ther. 2015 Nov;355(2):145-51. doi: 10.1124/jpet.115.227546. Epub 2015 Sep 1.

PMID:
26330539
25.

Effectiveness of opioid analgesics in chronic noncancer pain.

Ferrari R, Zanolin ME, Duse G, Visentin M.

Pain Pract. 2015 Mar;15(3):272-8.

PMID:
25914912
26.

Determinants of the activities of antifolates delivered into cells by folate-receptor-mediated endocytosis.

Zhao R, Visentin M, Goldman ID.

Cancer Chemother Pharmacol. 2015 Jun;75(6):1163-73. doi: 10.1007/s00280-015-2733-8. Epub 2015 Apr 7.

27.

Identification of Tyr residues that enhance folate substrate binding and constrain oscillation of the proton-coupled folate transporter (PCFT-SLC46A1).

Visentin M, Unal ES, Najmi M, Fiser A, Zhao R, Goldman ID.

Am J Physiol Cell Physiol. 2015 Apr 15;308(8):C631-41. doi: 10.1152/ajpcell.00238.2014. Epub 2015 Jan 21.

28.

Risk assessment of opioid misuse in italian patients with chronic noncancer pain.

Ferrari R, Duse G, Capraro M, Visentin M.

Pain Res Treat. 2014;2014:584986. doi: 10.1155/2014/584986. Epub 2014 Aug 10.

29.

Determination of polar organic compounds in atmospheric aerosols by gas chromatography with ion trap tandem mass spectrometry.

Visentin M, Pietrogrande MC.

J Sep Sci. 2014 Jul;37(13):1561-9. doi: 10.1002/jssc.201301332. Epub 2014 May 14.

PMID:
24723391
30.

The impact of 5-formyltetrahydrofolate on the anti-tumor activity of pralatrexate, as compared to methotrexate, in HeLa cells in vitro.

Visentin M, Unal ES, Goldman ID.

Cancer Chemother Pharmacol. 2014 May;73(5):1055-62. doi: 10.1007/s00280-014-2441-9. Epub 2014 Mar 29.

31.

The effectiveness of the quality program Pac-IficO to improve pain management in hospitalized cancer patients: a before-after cluster phase II trial.

Ripamonti CI, Prandi C, Costantini M, Perfetti E, Pellegrini F, Visentin M, Garrino L, De Luca A, Pessi MA, Peruselli C.

BMC Palliat Care. 2014 Mar 29;13(1):15. doi: 10.1186/1472-684X-13-15.

32.

The intestinal absorption of folates.

Visentin M, Diop-Bove N, Zhao R, Goldman ID.

Annu Rev Physiol. 2014;76:251-74. doi: 10.1146/annurev-physiol-020911-153251. Review.

33.

The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitor.

Visentin M, Unal ES, Zhao R, Goldman ID.

Cancer Chemother Pharmacol. 2013 Sep;72(3):597-606. doi: 10.1007/s00280-013-2231-9. Epub 2013 Jul 24.

34.

A new Italian questionnaire to assess caregivers of cancer patients' satisfaction with palliative care: multicenter validation of the post mortem questionnaire-short form.

Partinico M, Corà A, Ghisi M, Ouimet AJ, Visentin M; QPM Group.

J Pain Symptom Manage. 2014 Feb;47(2):298-306. doi: 10.1016/j.jpainsymman.2013.03.018. Epub 2013 Jul 12.

PMID:
23856096
35.

Enhancement of mitochondrial biogenesis with polyphenols: combined effects of resveratrol and equol in human endothelial cells.

Davinelli S, Sapere N, Visentin M, Zella D, Scapagnini G.

Immun Ageing. 2013 Jul 11;10(1):28. doi: 10.1186/1742-4933-10-28.

36.

Inhibition of the proton-coupled folate transporter (PCFT-SLC46A1) by bicarbonate and other anions.

Zhao R, Visentin M, Suadicani SO, Goldman ID.

Mol Pharmacol. 2013 Jul;84(1):95-103. doi: 10.1124/mol.113.085605. Epub 2013 Apr 22.

37.

Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.

Del Ross T, Ruffatti A, Visentin MS, Tonello M, Calligaro A, Favaro M, Hoxha A, Punzi L.

J Rheumatol. 2013 Apr;40(4):425-9. doi: 10.3899/jrheum.120576. Epub 2013 Feb 15.

PMID:
23418380
38.

Polymorphic thymidylate synthase gene impacts on overall survival of patients with epithelial ovarian cancer after platinum-based chemotherapy.

Biason P, Visentin M, Talamini R, Stopar A, Giorda G, Lucia E, Campagnutta E, Toffoli G.

Pharmacogenomics. 2012 Nov;13(14):1609-19. doi: 10.2217/pgs.12.136.

PMID:
23148637
39.

Parotid, breast, and fascial involvement in a patient who fulfilled the ACR criteria for Churg-Strauss syndrome.

Visentin MS, Salmaso R, Modesti V, Ometto F, Ruffatti A, Punzi L, Doria A.

Scand J Rheumatol. 2012 Aug;41(4):319-21. doi: 10.3109/03009742.2012.672593. No abstract available.

PMID:
22804574
40.

Interpretation of laboratory data and need for reference laboratories.

Pengo V, Denas G, Banzato A, Bison E, Bracco A, Visentin MS, Hoxha A, Ruffatti A.

Lupus. 2012 Jun;21(7):732-3. doi: 10.1177/0961203312437271.

PMID:
22635216
41.
42.

The antifolates.

Visentin M, Zhao R, Goldman ID.

Hematol Oncol Clin North Am. 2012 Jun;26(3):629-48, ix. doi: 10.1016/j.hoc.2012.02.002. Review.

43.

Substrate- and pH-specific antifolate transport mediated by organic anion-transporting polypeptide 2B1 (OATP2B1-SLCO2B1).

Visentin M, Chang MH, Romero MF, Zhao R, Goldman ID.

Mol Pharmacol. 2012 Feb;81(2):134-42. doi: 10.1124/mol.111.074823. Epub 2011 Oct 21.

44.

Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study.

Ruffatti A, Tonello M, Visentin MS, Bontadi A, Hoxha A, De Carolis S, Botta A, Salvi S, Nuzzo M, Rovere-Querini P, Canti V, Mosca M, Mitic G, Bertero MT, Pengo V, Boffa MC, Tincani A.

Rheumatology (Oxford). 2011 Sep;50(9):1684-9. doi: 10.1093/rheumatology/ker139. Epub 2011 Jun 7.

PMID:
21652586
45.

Mechanisms of membrane transport of folates into cells and across epithelia.

Zhao R, Diop-Bove N, Visentin M, Goldman ID.

Annu Rev Nutr. 2011 Aug 21;31:177-201. doi: 10.1146/annurev-nutr-072610-145133. Review.

46.

[Patients' satisfaction with pain management: the italian version of the Patient Outcome Questionnaire of the American Pain Society].

Ferrari R, Novello C, Catania G, Visentin M.

Recenti Prog Med. 2010 Jul-Aug;101(7-8):283-8. Italian.

PMID:
20842954
47.

Drug interactions among the epidermal growth factor receptor inhibitors, other biologics and cytotoxic agents.

Visentin M, Biason P, Toffoli G.

Pharmacol Ther. 2010 Oct;128(1):82-90. doi: 10.1016/j.pharmthera.2010.05.005. Epub 2010 Jun 11. Review.

PMID:
20542058
48.

Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy.

Cecchin E, Agostini M, Pucciarelli S, De Paoli A, Canzonieri V, Sigon R, De Mattia E, Friso ML, Biason P, Visentin M, Nitti D, Toffoli G.

Pharmacogenomics J. 2011 Jun;11(3):214-26. doi: 10.1038/tpj.2010.25. Epub 2010 Apr 6.

PMID:
20368715
49.

[The Italian version of NOPPAIN Scale: validation during education].

Novello C, Ferrari R, Scacco C, Visentin M.

Assist Inferm Ric. 2009 Oct-Dec;28(4):198-205. Italian.

PMID:
20222521
50.

Pain assessment in non-communicative patients: the Italian version of the Non-Communicative Patient's Pain Assessment Instrument (NOPPAIN).

Ferrari R, Martini M, Mondini S, Novello C, Palomba D, Scacco C, Toffolon M, Valerio G, Vescovo G, Visentin M.

Aging Clin Exp Res. 2009 Aug-Oct;21(4-5):298-306.

PMID:
19959918

Supplemental Content

Loading ...
Support Center